Alterations in serum lipid profile patterns have long been associated with malignancies, and their role remains controversial with respect to head and neck cancer. Due to an increased rate of neoplastic cell multiplication and reduced supply, there is increased utilization of lipids causing Hypolipidemia. Adding to this, tobacco contains carcinogens capable of damaging the cell membrane components including lipids resulting in further hypolipidemia. Thus the purpose of the present case control study is to discuss the alterations in plasma lipid profile in head and neck cancer patients in association with tobacco consumption. This hospital based study includes 80 cases of head and neck cancer patients and 50 controls. Plasma Lipids included are total cholesterol (TC), high density lipoprotein cholesterol (HDL), low density lipoprotein cholesterol (LDL), very low density lipoprotein cholesterol (LDL), triglycerides (TG). Student's "t test" was applied to the data acquired. Values of P < 0.05 were considered significant and P > 0.05 were considered statistically insignificant.
Introduction
Lipids are the main cell membrane components that are essential for various bi- Mevalonic acid having an essential role in DNA replication raised the possibility that a derangement in mevalonate synthesis might play a role in carcinogenesis [1] . Since 1980, a number of studies have revealed that there is a loss of cholesterol feedback control in cancer cells. This loss of the cholesterol feedback control leads to uncontrolled synthesis of mevalonate causing damaged DNA synthesis and uncontrolled hypocholestrelemia. Lipids are associated with cancer because they play an important role in cancer cellular integrity [2] [3] Lipids are useful for the study of variation in Cholesterol levels in many diseases.
It has been found that altered Serum Cholesterol levels are associated with breast and colorectal cancers [4] [5] [6] . Head and neck cancer is one of the leading causes of mortality and morbidity in India. Globally, it's the 6 th most common cancer in the world [7] . Tobacco is the most important etiological agent in head and neck cancer. There are 72 measurable carcinogens in tobacco and are classified as Group I carcinogens by IARC [8] .The most important players in tobacco causing head and neck cancer are 4-Nitroquinilone-1-oxide (NQO)
and Dimethylbenzanthracene (DMBA) [9] . The carcinogen in tobacco stimulates free radicals and reactive oxygen species release which in turn cause increase in 
Materials and Methods
The Table 1 .
Criteria for Cases Selection
Study Inclusion Criteria 1) Individuals with habit of smoking tobacco and chewing tobacco.
2) Individuals who were diagnosed clinically and histopathologically with Cancer.
3) Patients age 25 and above. 
Habit of Tobacco Consumption in the Subjects
Habit of tobacco consumption in one or the other form of smoking tobacco/chewing tobacco/chewing lime/chewing Areca nut is highly prevalent in India.
In our study, 97.5% of the patients with Head and Neck cancer were consuming tobacco in one form or other. The association of cancer of oral cavity and tobacco was 42.5%.The details regarding habit of tobacco consumption in association with head and neck cancer are provided in Figure 2 . Tobacco chewing form of readily available pouch (Gutka) and/or with lime was common in the patients with Oral cancer and Oropharyngeal cancer. A combination of Bidi and
Gutka was more commonly seen in Oral cavity cancer and in the female subjects the habit of Tobacco chewing along with Areca Nut was more commonly seen.
Tobacco smoking for more than 10 years was seen in 23 cases (28.75%) and smoking for more than 20 years was seen in 41 cases (51.25).
Results
A Significant decrease in Serum Total Cholesterol (P < 0.001), HDL (P < 0.001), LDL (P < 0.001), in Head and Neck cancer patients when compared to Controls.
Our results strengthen the evidence of an Inverse relation existing between Serum
Lipid levels and Cancer. Table 2 depicts the data recorded from the cases and controls. Table 3 shows that significant P values in Stage I, II, III, and IV in TC, HDL, and LDL. Non significant value of P was noted in Stage I, III, IV of VLDL, and TG. The total cholesterol in males and female with cancer in comparison to controls is depicted in Figure 3 . 
Conclusion
Our study reveals that there is a significant reduction in Lipid parameters (TC, HDL, LDL) in cancer patients. The study also reveals Stage II cancer showing Significant reduction in VLDL and TG. Hence in depth study is necessary involving larger populations to confirm this finding.
Discussion
The majority of the Cholesterol in the body is in the cell membrane structure which protect the cancer cell from oxidative killing and also chemotherapeutic agents [13] . Furthermore all cases in our study had habit of tobacco consumption in one form or other. Carcinogens in tobacco are responsible for increase in peroxide free radical production due to oxidation/peroxidation of Poly unsaturated free fatty acids [17] . This results in further consumption in lipids adding to already decreased plasma lipids.
In 1974, Rose et al. [18] reported that serum cholesterol was found lower in cancer colon patients, followed by Kark et al. [19] reporting low cholesterol levels in lung cancer patients. Following these discoveries many researchers found Hypolipedimia in several cancers though alterations were seen with respect to LDL, VLDL, TG, reduced levels of HDL seen in most of the studies. Schatzkin et al. [2] and Chyou et al. [20] observed an inverse trend between lower serum cholesterol in head and neck cancer as well as in esophageal cancers. The lower serum lipid status may be considered a useful indicator for initial changes occurring in the neoplastic cells. In the study done by Omoti et al. the mean serum cholesterol & LDL in the cancer patients were significantly lower than those of controls [21] .
In one study done at The Edith Wolfson Medical Centre in, Israel they found that the LDL levels showed that a 1 mg/dl increase in LDL was accompanied by a relative 2.4% and 2.5% reduction in odds of hematological cancer and fever/ sepsis respectively [22] . This leads to the question if there can be a value so significant that we can determine the prognosis of a patient by the lipid values.
Aexopoulos et al. [23] had found non-significant difference in serum triglycerides between cases and controls. Study done by Nydegger et al. revealed that serum triglycerides and cholesterol levels were markedly decreased in cancer patients [24] . It shows that there is significant difference between cases and controls with respect to TC, HDL, and LDL. In our study we noted that though the mean levels of VLDL, TG in the cases were lower compared to controls, they weren't significant.
However values of VLDL, TG in Stage II cancer shows significant P value. Hence to correlate with our findings an in depth study is necessary to find out the changes in lipid levels per stage of cancer by involving a larger populations based study. 
